glp-1 news november 5 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Consumers' Expectations about GLP-1 Drugs

Exenatide readily enters the brain when injected intravenously into mice (102)

For patients seeking dual-compound therapy, GLP-Squared injection begins at $249 monthly

It helps to: Including semaglutide in our medical weight loss programs extends many benefits, each contributing to a holistic and sustainable transformation

January 5, 2026: Dozens of Ozempic Vision Loss Lawsuits Now Grouped Together in Federal Court The new MDL for GLP-1 vision loss cases has now been established, with 29 cases placed before one judge

N Engl J Med 1990

Acknowledgments We wish to thank the Scientific Bureau of the University of Catania for language support